Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adma Biologics (NQ: ADMA )

4.080 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.080
Bid (Size) 4.050 (1)
Ask (Size) 4.080 (1)
Prev. Close 4.080
Today's Range 4.080 - 4.080
52wk Range 1.850 - 4.300
Shares Outstanding 196,357,149
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Recap: ADMA Biologics Q1 Earnings
 
Via Benzinga
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire

Performance

YTD
+5.43%
+5.43%
1 Month
+19.30%
+19.30%
3 Month
+16.91%
+16.91%
6 Month
+25.93%
+25.93%
1 Year
+99.02%
+99.02%

More News

Read More
A Preview Of ADMA Biologics's Earnings
Via Benzinga
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Amendment to Credit Agreement
From ADMA Biologics, Inc.
Via GlobeNewswire
Earnings Outlook For ADMA Biologics
Via Benzinga
Looking Into ADMA Biologics's Return On Capital Employed
Via Benzinga
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
ADMA Biologics, C3.ai And Other Big Stocks Moving Higher On Friday
Via Benzinga
Dow Down 150 Points; US Durable Goods Orders Drop In February
Via Benzinga
Oxford Industries, Express And 3 Stocks To Watch Heading Into Friday
Via Benzinga
After-Hours Action: Why ADMA Biologics Shares Are Trading Higher
Via Benzinga
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Earnings Scheduled For March 23, 2023
Via Benzinga
7 A-Rated Penny Stocks Worth Betting On
Via InvestorPlace
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine
Via InvestorPlace
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
From ADMA Biologics, Inc.
Via GlobeNewswire
Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better
Via Benzinga
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022
Via Benzinga
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Proposed Public Offering of Common Stock
From ADMA Biologics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.